An F.D.A. sign-off for aducanumab would make finding a good treatment harder.
A health journalist is getting a front-row seat to one of the most-anticipated pediatric trials in history.
The magazine’s Ethicist columnist on the importance of control groups and elderly parents’ risky behavior.
Some vaccine experts worry that “unblinding” the trials and giving all of the volunteers vaccines would tarnish the long-term results.
You might assume that 95 out of every 100 people vaccinated will be protected from Covid-19. But that’s not how the math works.
Come spring, Americans may have their choice of several so-so coronavirus vaccines — with no way of knowing which one is best.
A curcumin extract eased pain, stiffness and physical function in those with osteoarthritis of the knee.
George Washington University Hospital invited me to participate in Moderna’s vaccine trial because I am triple-risk: a Black woman, a Type 1 diabetic and asthmatic.
More than 70,000 Covid-19 patients have received it. We have no idea whether it helps.
A clinical trial showed that remdesivir helped hospitalized patients. Now researchers are asking whether when the drug is paired with another antiviral drug, patients will recover faster.
How do you sign up? Will you get paid? Who will cover the costs if you get sick? Here’s a look at the basics.
It’s tempting to speed up development in a pandemic, but there are good reasons to stick to scientific standards.